Literature DB >> 7769289

Mortality of Candida albicans-infected mice is facilitated by superinfection of Escherichia coli or administration of its lipopolysaccharide.

G Akagawa1, S Abe, H Yamaguchi.   

Abstract

Pathogenesis of complex infection with Candida albicans and gram-negative bacteria was studied by determining the influence of infection with Escherichia coli or injection of E. coli lipopolysaccharide (LPS) on mortality of C. albicans-infected mice. Mice were infected intravenously with lethal doses of C. albicans, then treated intravenously at various times with viable E. coli or E. coli LPS, which individually were not lethal. Treatments 3 h after C. albicans infection clearly facilitated the death of the mice. Corresponding to this facilitated death, production of tumor necrosis factor (TNF) in sera was augmented 2 h after LPS injection into the infected mice. Similar increased production of TNF was also observed in mice treated with a nonlethal combination of heat-killed C. albicans and LPS. The number of viable C. albicans in kidneys of the infected mice was increased by LPS treatment, which was assumed to be the main cause of the greater mortality rate.

Entities:  

Mesh:

Substances:

Year:  1995        PMID: 7769289     DOI: 10.1093/infdis/171.6.1539

Source DB:  PubMed          Journal:  J Infect Dis        ISSN: 0022-1899            Impact factor:   5.226


  13 in total

Review 1.  Candida peritonitis: an update on the latest research and treatments.

Authors:  Herman Anthony Carneiro; Anastasios Mavrakis; Eleftherios Mylonakis
Journal:  World J Surg       Date:  2011-12       Impact factor: 3.352

Review 2.  Medically important bacterial-fungal interactions.

Authors:  Anton Y Peleg; Deborah A Hogan; Eleftherios Mylonakis
Journal:  Nat Rev Microbiol       Date:  2010-03-29       Impact factor: 60.633

3.  Coinfection with Borrelia burgdorferi and the agent of human granulocytic ehrlichiosis alters murine immune responses, pathogen burden, and severity of Lyme arthritis.

Authors:  V Thomas; J Anguita; S W Barthold; E Fikrig
Journal:  Infect Immun       Date:  2001-05       Impact factor: 3.441

4.  Th2 allergic immune response to inhaled fungal antigens is modulated by TLR-4-independent bacterial products.

Authors:  Jenna B Allard; Lisa Rinaldi; Matthew J Wargo; Gilman Allen; Shizuo Akira; Satoshi Uematsu; Matthew E Poynter; Deborah A Hogan; Mercedes Rincon; Laurie A Whittaker
Journal:  Eur J Immunol       Date:  2009-03       Impact factor: 5.532

5.  Escherichia coli and TNF-alpha modulate macrophage phagocytosis of Candida glabrata.

Authors:  Donavon J Hess; Michelle J Henry-Stanley; Catherine M Bendel; Bin Zhang; Mary-Alice Johnson; Carol L Wells
Journal:  J Surg Res       Date:  2008-08-27       Impact factor: 2.192

Review 6.  Production and function of cytokines in natural and acquired immunity to Candida albicans infection.

Authors:  R B Ashman; J M Papadimitriou
Journal:  Microbiol Rev       Date:  1995-12

7.  Risk factors for and clinical implications of mixed Candida/bacterial bloodstream infections.

Authors:  S-H Kim; Y K Yoon; M J Kim; J W Sohn
Journal:  Clin Microbiol Infect       Date:  2012-06-01       Impact factor: 8.067

8.  Candida spp. and gingivitis in children with nephrotic syndrome or type 1 diabetes.

Authors:  Dorota Olczak-Kowalczyk; Beata Pyrżak; Maria Dąbkowska; Małgorzata Pańczyk-Tomaszewska; Grażyna Miszkurka; Izabela Rogozińska; Ewa Swoboda-Kopeć; Dariusz Gozdowski; Angelika Kalińska; Anna Piróg; Małgorzata Mizerska-Wasiak; Maria Roszkowska-Blaim
Journal:  BMC Oral Health       Date:  2015-05-08       Impact factor: 2.757

9.  Candida albicans Inhibits Pseudomonas aeruginosa Virulence through Suppression of Pyochelin and Pyoverdine Biosynthesis.

Authors:  Eduardo Lopez-Medina; Di Fan; Laura A Coughlin; Evi X Ho; Iain L Lamont; Cornelia Reimmann; Lora V Hooper; Andrew Y Koh
Journal:  PLoS Pathog       Date:  2015-08-27       Impact factor: 6.823

10.  Invasive Candida Infection after Upper Gastrointestinal Tract Surgery for Gastric Cancer.

Authors:  Evgeni Brotfain; Gilbert Sebbag; Michael Friger; Boris Kirshtein; Abraham Borer; Leonid Koyfman; Dmitry Frank; Yoav Bichovsky; Jochanan G Peiser; Moti Klein
Journal:  Int J Surg Oncol       Date:  2017-11-06
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.